Overview

Study to Assess the Effect Of Alosetron On Mucosal Blood Flow

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will look at colonic mucosal blood flow in subjects who have taken alosetron vs placebo and healthy volunteers vs diarrhea-predominant Irritable Bowel Syndrome (d-IBS) patients.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Alosetron